Vaccines

Strategic Research Insights (SRI) has over 15 years of deep expertise in vaccine research, working extensively across the US and global markets. We have worked extensively on pediatric, adolescent, and adult vaccines in numerous countries, contributing significantly to our reputation as industry leaders in vaccine research. Key disease areas covered include influenza, COVID-19, respiratory syncytial virus (RSV), pneumococcal infections, HPV, MMR, meningococcal diseases, dengue, and other vaccine-preventable diseases. SRI’s research also extends to emerging vaccine needs like pandemic preparedness and combination vaccines.

SRI’s project types are diverse and comprehensive, encompassing sales activity recall, message effectiveness, visual aid assessment, usage segmentation, trademark and logo testing, concept and prototype testing, opportunity assessment, market landscape analysis, usability studies, and extensive research involving physicians, patients, and caregivers.

Unique expertise includes estimating vaccine series completion rates, identifying barriers to completion, measuring the societal burden of diseases, and analyzing healthcare providers’ knowledge and behaviors towards vaccination recommendations. We also conduct ongoing tracking studies (monthly, quarterly, biannual), advertising impact evaluations, and patient journey analyses to support strategic vaccine development, market entry, and lifecycle management.